ETHERLive
ETHERLive delivers real-time price and volume data across 16+ exchanges to users in a clear and easy-to-understand package. Users can get up-to-the-second updates for each exchange/currency pair, as well as aggregated market averages for each exchange, currency, and the market as a whole. It also provides a global converted average of all the currency pairs monitored by ETHNews, converted to USD.

---

24hr ---
--%
Tuesday Dec 19th 2017
RESOURCES

The Basics

Learn the basics of Ethereum and various cryptocurrency technologies

Learn More

What is Ethereum?

Understand the underlying principles of the Ethereum Platform

Learn More

The Blockchain

Discover the revolutionizing technology known as the blockchain

Learn More
SUBMIT

Press Release

Submit a press release for consideration on ETHNews

Submit Press

Story / Dapp

Submit a story or DAPP to be considered for publication on ETHNews.

Submit Story

Explanation

Submit "Ethereum Explainer" content for consideration to be featured on ETHNews

Submit Topic
ETHNews Logo
---
--%
Home
News
Etherlive
Ether Price Analysis
Resources
Contact Us

Pfizer and Genentech Turn To Ethereum Blockchain

By

Jeremy

Nation

WriterETHNews.com

Industry giants Pfizer and Genentech will work with blockchain startup Chronicled and supply chain company The LinkLab to develop an Ethereum-based platform.

Major pharmaceutical conglomerates Pfizer and Genentech, together constituting a market cap greater than $300 billion, recently announced the MediLedger blockchain platform, powered by JP Morgan's enterprise-focused, Ethereum-based Quorum, designed to keep counterfeit goods out of medical supply chains.

The MediLedger project is slated to go through various pilot tests in the coming months that simulate marketplace supply-chain conditions of both Genentech and Pfizer. Of key importance is finding a means to scale the system rationally to suit the needs of both pharma giants, the supply chains of which are sizeable and must consistently handle millions of data points.

In July of 2017, blockchain startup Chronicled, in partnership with the supply chain consulting company The LinkLab, completed a pilot test of a blockchain-based system for medical supply chains as reported by ETHNews. Now Pfizer is ready to hand the reigns of platform development of the MediLedger project to The LinkLab and Chronicled.

Chronicled CEO Ryan Orr described MediLedger as a permissioned blockchain that takes into account a necessity to form consensus among counterparties, each of which will control a node to maintain an immutable, transparent, and ubiquitous deployment of data to the system. Orr said, "The pharma industry consists of large conservative companies, so it takes a lot of confidence to build up a network like this."

According to Orr, outdated centralized data processing methods may be susceptible to security vulnerabilities that could result in a loss of important and often valuable data.

By way of the Ethereum-based system of provenance that is in development by Chronicled and The LinkLab, pharmaceutical manufacturers can identify defective pills before they enter supply chains, thanks to cryptographic timestamps.

Describing Genentech's focus on safety, vice president of Managed Care and Operations Marc Watrous affirmed:

"Ensuring the safety of people receiving our medicines is of utmost importance to us. We look forward to exploring the potential benefits that this pilot could provide in protecting our medicines across the entire supply chain."

Jeremy Nation

Jeremy Nation is a writer living in Los Angeles with interests in technology, human rights, and cuisine. He is a full time staff writer for ETHNews and holds value in Ether.

ETHNews is commited to its Editorial Policy

Like what you read? Follow us on Twitter @ETHNews_ to receive the latest Pfizer, Genentech or other Ethereum healthcare news.